FR940204-2-00086 FR940204-2-00061 Advisory Committees; Tentative Schedule of Meetings for 1994 AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing a tentative schedule of forthcoming meetings of its public advisory committees for 1994. At the request of the Commissioner of Food and Drugs (the Commissioner), the Institute of Medicine (the IOM) conducted a study of the use of FDA's advisory committees. The IOM recommended that the agency publish an annual tentative schedule of its meetings in the Federal Register . In response to that recommendation, FDA is publishing its first annual tentative schedule of meetings. FOR FURTHER INFORMATION CONTACT: Donna M. Combs, Committee Management Office (HFA&hyph;306), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301&hyph;443&hyph;2765. SUPPLEMENTARY INFORMATION: The IOM, at the request of the Commissioner, undertook a study of the use of FDA's advisory committees. In its final report, the IOM recommended that FDA adopt a policy of publishing an advance yearly schedule of its upcoming public advisory committee meetings in the Federal Register . FDA is implementing this recommendation with the publication of this notice in the Federal Register . The annual publication of tentatively scheduled advisory committee meetings will provide both advisory committee members and the public with the opportunity to schedule, in advance, attendance at FDA's upcoming advisory committee meetings. The schedule is tentative and amendments to this notice will not be published in the Federal Register . FDA will, however, publish a Federal Register notice 15 days in advance of each upcoming advisory committee meeting, announcing the meeting (21 CFR 14.20). The following list announces FDA's tentatively scheduled advisory committee meetings for 1994: 1Committee name 1Dates of meetings OFFICE OF THE COMMISSIONER ␣ Board of Tea Experts February 24&hyph;25 Science Board to the Food and Drug Administration February 23&hyph;24 June 28 October 20&hyph;21 CENTER FOR BIOLOGICS EVALUATION AND RESEARCH ␣ Allergenic Products Advisory Committee June 6&hyph;7 November 21&hyph;22 Biological Response Modifiers Advisory Committee May 25&hyph;26 ␣ September 1&hyph;2 ␣ December 8&hyph;9 Blood Products Advisory Committee March 24&hyph;25 ␣ May 19&hyph;20 ␣ September 29&hyph;30 ␣ December 15&hyph;16 Vaccines and Related Biological Products Advisory Committee January 27&hyph;28 ␣ August 23&hyph;24 ␣ November 17&hyph;18 CENTER FOR DRUG EVALUATION AND RESEARCH ␣ Anesthetic and Life Support Drugs Advisory Committee January 24 (subcommittee meeting) ␣ March 1&hyph;2 (subcommittee meeting) May 19&hyph;20 Anti-Infective Drugs Advisory Committee March 24&hyph;25 ␣ October 20&hyph;21 Antiviral Drugs Advisory Committee May 19 (joint meeting with Nonprescription Drugs Advisory Committee) ␣ May 20 Arthritis Advisory Committee January 27&hyph;28 ␣ June 13&hyph;14 Cardiovascular and Renal Drugs Advisory Committee March 24&hyph;25 June 9&hyph;10 Dermatologic Drugs Advisory Committee February 16 (joint meeting with Nonprescription Drugs Advisory Committee) November 3&hyph;4 Drug Abuse Advisory Committee April 19&hyph;20 ␣ August 30&hyph;31 December 5&hyph;6 Endocrinologic and Metabolic Drugs Advisory Committee March 17&hyph;18 Fertility and Maternal Health Drugs Advisory Committee June 23&hyph;24 Gastrointestinal Drugs Advisory Committee February 17 Generic Drugs Advisory Committee January 11&hyph;12 Medical Imaging Drugs Advisory Committee April 22 November 18 Nonprescription Drugs Advisory Committee February 16 (joint meeting with Dermatologic Drugs Advisory Committee) May 18 May 19 (joint meeting with Antiviral Drugs Advisory Committee) July 28&hyph;29 September 22&hyph;23 Oncologic Drugs Advisory Committee March 29 June 7 Peripheral and Central Nervous System Drugs Advisory Committee March 14&hyph;15 June 6&hyph;7 September 26&hyph;27 Psychopharmacologic Drugs Advisory Committee April 25&hyph;26 July 18&hyph;19 Pulmonary-Allergy Drugs Advisory Committee May 23&hyph;24 October 20&hyph;21 CENTER FOR FOOD SAFETY AND APPLIED NUTRITION Food Advisory Committee April 5&hyph;6 June 20&hyph;21 October 10&hyph;11 CENTER FOR DEVICES AND RADIOLOGICAL HEALTH Device Good Manufacturing Practice Advisory Committee No meetings planned Medical Devices Advisory Committee: ␣ Anesthesiology and Respiratory Therapy Devices Panel May 17 Circulatory System Devices Panel March 7&hyph;8 June 6&hyph;7 October 3&hyph;4 December 5 Clinical Chemistry and Clinical Toxicology Devices Panel April 25&hyph;26 September 12&hyph;13 Dental Products Panel March 28&hyph;30 June 14&hyph;16 September 22&hyph;23 December 6&hyph;8 Ear, Nose, and Throat Devices Panel June 23&hyph;24 Gastroenterology-Urology Devices Panel March 24&hyph;25 ␣ July 14&hyph;15 ␣ October 13&hyph;14 General and Plastic Surgery Devices Panel March 17&hyph;18 ␣ September 29&hyph;30 General Hospital and Personal Use Devices Panel April 21&hyph;22 ␣ September 14&hyph;15 Hematology and Pathology Devices Panel June 6 ␣ November 7 Immunology Devices Panel May 19&hyph;20 ␣ September 23 Microbiology Devices Panel June 9 Neurological Devices Panel July 8&hyph;9 ␣ September 16&hyph;17 Obstetrics-Gynecology Devices Panel April 14&hyph;15 June 16&hyph;17 ␣ September 22&hyph;23 Ophthalmic Devices Panel February 24&hyph;25 ␣ May 19&hyph;20 ␣ October 20&hyph;21 Orthopedic and Rehabilitation Devices Panel May 20 ␣ October 21 Radiologic Devices Panel May 2 ␣ August 29 ␣ December 12 National Mammography Quality Assurance Advisory Committee February 17&hyph;18 ␣ May 11&hyph;13 ␣ August 3&hyph;5 ␣ November 3&hyph;5 Technical Electronic Product Radiation Safety Standards Committee July 19 CENTER FOR VETERINARY MEDICINE ␣ Veterinary Medicine Advisory Committee April 20&hyph;21 ␣ October 26&hyph;27 NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH ␣ Advisory Committee on Special Studies Relating to the Possible Long-Term Health Effects of Phenoxy Herbicides and Contaminants (Ranch Hand Advisory Committee) June 1&hyph;2 Science Board to the National Center for Toxicological Research June 14&hyph;15 Dated: January 31, 1994. Jane E. Henney, Deputy Commissioner for Operations. [FR Doc. 94&hyph;2468 Filed 2&hyph;3&hyph;94; 8:45 am] BILLING CODE 4160&hyph;01&hyph;F
